Background: The aim of the study was to evaluate the clinical safety and usefulness of esophageal dissection under laparoscopic monitoring during transhiatal esophagectomy for esophageal cancer. Patients and Methods:The study group of 115 patients included 102 men and 13 women. The mean age was 57 (range 32-79)years. Tumor histology showed a squamous cell carcinoma in 75% and an adenocarcinoma in 25% of cases. According to the American Joint Committee on Cancer classification, 3 patients were classified as stage I, 19 as stage IIA, 24 as stage IIB, 64 as stage III, and 5 as stage IVA. Mean operating time was 4.5 ± 1 h. Results: Ten significant intraoperative complications were observed(9 hemorrhages, 1 death). The mean blood loss was 900(range 300-2,100) ml. Postoperative complications occurred in 61% of the patients; the most frequent were pulmonary complications (27%), recurrent laryngeal nerve injury (17.4%), anastomotic stricture (14%), and anastomotic leak (10.4%). Early re-laparotomy was performed in 6% of the patients. Hospital mortality rate was 9%. Mean hospital stay was 34 (range 5-64) days. Conclusion:Video-assisted transhiatal esophagectomy is a useful method, but does not allow a vision-guided removal of the upper esophagus. The method does not prevent or diminish the number of intra- and postoperative complications of esophageal resection.

This content is only available via PDF.
2005
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.